Navigation Links
OncoSec Medical to Present at the 15th Annual BIO CEO & Investor Conference
Date:2/6/2013

able to minimize detrimental effects resulting from currently available cancer treatments such as surgery, systemic chemotherapy or immunotherapy and other treatment alternatives.  OncoSec Medical's core technology is based upon its proprietary use of an electroporation platform to dramatically enhance the delivery and uptake of a locally delivered DNA-based immunocytokine (ImmunoPulse) or chemotherapeutic agent (NeoPulse). Treatment of various solid cancers using these powerful and targeted anti-cancer agents has demonstrated selective destruction of cancerous cells while sparing healthy normal tissues during early and late stage clinical trials. OncoSec's clinical programs include three Phase II clinical trials for ImmunoPulse targeting lethal skin cancers. More information is available at http://www.oncosec.com/.

This press release contains forward looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Any statements in this release that are not historical facts may be considered such "forward looking statements." Forward looking statements are based on management's current preliminary expectations and are subject to risks and uncertainties which may cause our results to differ materially and adversely from the statements contained herein. Some of the potential risks and uncertainties that could cause actual results to differ from those predicted include our ability to raise additional funding, our ability to acquire, develop or commercialize new products, uncertainties inherent in pre-clinical studies and clinical trials, unexpected new data, safety and technical issues, competition and market conditions. These and additional risks and uncertainties are more fully described in OncoSec Medical's filings with the Securities and Exchange Commission. Undue reliance should not be placed on forward look
'/>"/>

SOURCE OncoSec Medical Incorporated
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. OncoSec Medical to Present at Noble Financial Capital Markets Ninth Annual Equity Conference on January 22
2. OncoSec Medical Announces $7.2 Million Public Offering
3. OncoSec Medical to Present Data at DNA Vaccines 2012 Conference
4. OncoSec Medical Reports Positive Preliminary Efficacy Results from Phase II Study of ImmunoPulse in Metastatic Melanoma Patients
5. OncoSec Medical Reports Positive Interim Efficacy Results from Phase IV Study of NeoPulse in Skin Cancer Patients
6. OncoSec to Present at Upcoming Healthcare and Investor Conferences
7. OncoSec Granted New Patent from China
8. OncoSec to Present at the Rodman & Renshaw 2012 Annual Global Investment Conference
9. OncoSec Featured on KTVU-TV News and in San Francisco Chronicle
10. OncoSec OMS ElectroChemotherapy for Head and Neck Cancer Shows Enhanced Quality of Life in Two Randomized Phase III Studies
11. OncoSec Establishes Clinical Site for Its Phase II Merkel Cell Carcinoma Trial at University of California San Francisco (UCSF)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... July 23, 2014 Research and Markets ... Medical Gloves (Exam and Surgical) Markets Worldwide 2014" ... http://photos.prnewswire.com/prnh/20130307/600769 The purpose of this report ... Disposable Medical (Exam and Surgical) Gloves. The report discusses ... these products. Topics covered include product definitions, ...
(Date:7/23/2014)... , July 23, 2014  The management team ... ) will hold a conference call on July ... second quarter ended June 30, 2014.  The call ... 2014Time: , 8:30 am EDTDial-in numbers: , Toll ... (412) 317-0790Webcast (live & archive): , www.columbialabs.com ...
(Date:7/23/2014)... July 23, 2014  Silk Road Medical, Inc., ... treatment of intra- and extra-cranial cerebrovascular disease, announced ... to the position of Chief Technology Officer.  ... company,s Research and Development efforts across its family ... Prior to joining Silk Road Medical, Michael ...
Breaking Medicine Technology:Disposable Medical Gloves (Exam and Surgical) Markets Worldwide 2014 2Disposable Medical Gloves (Exam and Surgical) Markets Worldwide 2014 3Disposable Medical Gloves (Exam and Surgical) Markets Worldwide 2014 4Columbia Laboratories to Discuss Second Quarter 2014 Financial Results on July 31st Conference Call 2Silk Road Medical Appoints Ground Breaking Innovator as Chief Technology Officer 2Silk Road Medical Appoints Ground Breaking Innovator as Chief Technology Officer 3
... Mich., Feb. 1, 2012 EPS Security (EPS), a leading ... include a new Medical Alert service later this ... communication device with EPS, ( www.EpsSecurity.com ) award-winning staff of ... senior citizens wishing to remain living independently at home. ...
... 2012  The Unilens Vision Inc. (OTC Markets Group ... Directors today declared a quarterly cash dividend of $0.045 per ... of record at the close of business on February 10, ... "The Eye Care Professionals Specialty Contact Lens Company" ...
Cached Medicine Technology:EPS Security to Add "Medical Alert" Services for Independent Seniors 2Unilens Vision Inc. Declares Quarterly Cash Dividend of $0.045 Per Share 2
(Date:7/23/2014)... Leading experts have joined together for the first time ... help millions of people worldwide suffering from the condition. ... can cause irreversible joint damage if left untreated. , ... psoriasis, which causes a red, scaly rash, and affects ... , Around one in five go on to ...
(Date:7/23/2014)... women has identified three genetic changes linked to an ... Vanderbilt University investigators, was published online July 20 in ... one of the most common malignancies among women worldwide, ... disease have focused on women of European ancestry. , ... between East Asian women and those of European ancestry, ...
(Date:7/23/2014)... July 23, 2014 On July 21, 2014, ... safety advocate Jack Tracey for an episode that spoke about ... episode, Deierlein asks Tracey to talk some about the formation ... in its mission, it was started right here in Charleston, ... it was to help survivors of sexual abuse. Their purpose ...
(Date:7/23/2014)... The Circuelle Foundation compiled and ... uncovering the importance of breast self-exams (BSE). The ... breast self-exams is contradictory and can be confusing ... keeping this healthy ritual. , “Women are confused ... of breast self-exams and becoming breast aware,” explains ...
(Date:7/23/2014)... (PRWEB) July 23, 2014 Psoriasis is ... dry, red patches on the skin—but this disease is ... risk for cardiovascular disease, some cancers, certain types of ... a genetic disease, since it occurs in families and ... present, which means that symptoms must be managed at ...
Breaking Medicine News(10 mins):Health News:Psoriatic arthritis patients need better screening, warns panel of experts 2Health News:Vanderbilt-led study identifies genes linked to breast cancer in East Asian women 2Health News:My Positive Perspective Airs Episode to Raise Attention to the Group Darkness to Light 2Health News:Historical and Current Research Points to Importance of Breast Self-Exams 2Health News:MedicationDiscountCard.com Makes Tazorac Discount Cards For Psoriasis Sufferers 2
... method for early confirmation of bile duct, pancreatic cancers, , ... they have developed new tests that make it easier to ... a study, the new tests more than doubled the detection ... often are not discovered until their later stages. , "The ...
... their chance of surviving an in-hospital cardiac arrest and do ... study has shown. The study further showed that ... patient,s choice about whether to have orders in place to ... also involved researchers in the Iowa City Veterans Affairs Medical ...
... leader in overseas health care facilitation, launches its online presence ... The exclusive website is custom-built for existing and potential Veiovis ... seeking accessible and affordable first-rate health care solutions. , ... reachable and viable for consumers underlies the intuitive design of ...
... ... ... 3, 2009 -- Changing global health is challenging health professionals everywhere to rethink how ... human services professionals to network and collaborate with colleagues from across the globe and ...
... Haemacure Completes US$2.5 Million Bridge Financing from ... Haemacure Corporation (TSX:HAE), a Montreal-based specialty bio-therapeutics company, announces ... , TSX:ANP) have today closed a senior secured bridge ... of US$2.5 million. The loan was described in detail ...
... June 3 Home for Life Solutions(TM) and Tunstall ... implement the "Telehealth Pilot Project." The one-year Pilot Project ... on Tunstall technology and products in the retirement community ... patient satisfaction of the telehealth system. , , ...
Cached Medicine News:Health News:New Tests Spot Tough-to-Detect Cancers Sooner 2Health News:Hospitalized patients need better understanding of CPR and outcomes 2Health News:Hospitalized patients need better understanding of CPR and outcomes 3Health News:Veiovis Launches Medical Travel Web Portal 2Health News:Veiovis Launches Medical Travel Web Portal 3Health News:ESRI Health GIS Conference to Feature Speakers Innovating Health Care 2Health News:ESRI Health GIS Conference to Feature Speakers Innovating Health Care 3Health News:ESRI Health GIS Conference to Feature Speakers Innovating Health Care 4Health News:Haemacure and Angiotech Enter License, Distribution and Supply Agreements for Haemacure's All-Human Fibrin Sealant and Thrombin Products 2Health News:Haemacure and Angiotech Enter License, Distribution and Supply Agreements for Haemacure's All-Human Fibrin Sealant and Thrombin Products 3Health News:Haemacure and Angiotech Enter License, Distribution and Supply Agreements for Haemacure's All-Human Fibrin Sealant and Thrombin Products 4Health News:New Telehealth Pilot Project to Evaluate Technology Solutions for U.S. Market 2
The GoodKnight® 425 Bi-Level® device is suitable for travel and includes features such as automatic altitude compensation, optional cigarette lighter adapter and portable battery pack...
... Bi-Flex bi-level system, while in BiPAP mode, ... takes to change from EPAP to IPAP. ... automatically triggers the device to cycle between ... patients breathing rhythm. Auto-Trak also compensates for ...
Functional trainer...
... This control is specifically designed ... Lipoprint LDL electrophoretic system for separation ... lipoprotein fractions and subfractions in patient ... VLDL, Midbands C, B, and A ...
Medicine Products: